The 22nd edition of Telangana government’s annual Life Sciences conference BioAsia 2025 that continued to meet its goals of serving as a global platform for deliberations on a wide ranging issues and developments, facilitating business interactions and showcasing products and solutions concluded in Hyderabad on Wednesday.
IT and Industries Minister D. Sridhar Babu said BioAsia 2025 received more than 3,000 delegates making it the largest in the series, saw at least 11 companies committing to invest more than ₹5,000 crore in the Green Pharma City near Hyderabad and set the stage for as many as 200 high impact B2B meetings.
Additionally, US drugmaker MSD said it has decided to ramp up its headcount in India. Executive Vice-President, Chief Information and Digital officer Dave Williams told a BioAsia session that in India MSD operates in multiple therapy areas, including oncology, diabetes, vaccines and animal health. “We’re also proud to manufacture products in India for India and the rest of the world. And just this week we opened our new technology centre in Hyderabad.”
By the end of this year MSD expects to have roughly 2,700 employees across its India sites. “In a couple years I fully expect we’ll double that number or more, “ he said. The number at present is around 1,800.
In the run to BioAsia, US biopharma giant Amgen opened its innovation and technology facility on which it will be investing $200 million and hire around 2,000 people by this year. German cellular research, cell therapy and cell manufacturing solutions provider Miltenyi Biotec launched a cell and gene therapy centre of excellence (CoE) in Hyderabad.
Data innovation partner for the Life Sciences sector Agilisium said it is launching a Life Sciences Innovation and Talent Development Lab in Hyderabad and committed to creating 2,000 job opportunities over the next 36 months.
Vaccine testing facility
Addressing the valedictory session, Mr.Sridhar Babu spoke of the strides made by Telangana in the pharma space. He appealed to the Union Minister of Coal and Mines G. Kishan Reddy, who was the chief guest, for the setting up of a vaccine testing centre in Hyderabad. Prime Minister Narendra Modi had given this assurance. In the absence of such a facility, every batch of the vaccine made in Telangana had to be sent to Kasauli in Himachal Pradesh for getting the approval.
Mr.Kishan Reddy said Hyderabad has emerged as the pharmacy of the world and it is only appropriate that BioAsia hosting top leaders from the world come here to discuss technology and sustainable practices. He detailed various schemes and measures initiated by the Modi-led government at the Centre towards industrial development, financial inclusion and access to loans for businesses, especially those small.
Semantic Web Tech; Genica Bioscience; ProEnz Biosciences; Boltzmann Labs; and Utopia Therapeutics were the five startups out of the 84 such shortlisted for Bio Asia 2025 that were recognised for their work during the closing ceremony.
